Huffington Post: The Unnecessary Persistence of Tuberculosis
Sandro Galea, dean and professor at Boston University’s School of Public Health, and C. Robert Horsburgh Jr., professor at the Boston University Schools of Public Health and Medicine

“… Why … with a cure at our disposal, is our progress on TB so slow? The answer lies not in the treatment itself, but in our capacity to deliver treatment effectively, and in the broader conditions that weaken the health systems needed to help deal with the disease. … Engagement with reducing the burden of this preventable disease requires an investment in health systems, building on funding to sustain infrastructure that can support programs on a large-scale. … With so many current TB deaths occurring in low- and middle-income countries, it is clear that any attempt to end TB will require an investment where it matters most, helping poorer countries build their health systems, raising awareness about TB, and engaging with the challenges of delivering health services to the poorest, worldwide. This is an investment that will pay rich dividends; nations with resources need to double down now” (10/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.